United States Bevacizumab Biosimilar Market Research Report Forecast 2017-2021

May 2017 | 134 pages | ID: U027BD0359DEN
S&P Consulting

Abstracts

The United States Bevacizumab Biosimilar Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Bevacizumab Biosimilar industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Bevacizumab Biosimilar market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals

United States Bevacizumab Biosimilar Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

United States Bevacizumab Biosimilar Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 BEVACIZUMAB BIOSIMILAR MARKET OVERVIEW

1.1 Product Overview and Scope of Bevacizumab Biosimilar
1.2 Bevacizumab Biosimilar Market Segmentation by Type
  1.2.1 United States Production Market Share of Bevacizumab Biosimilar by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Bevacizumab Biosimilar Market Segmentation by Application
  1.3.1 Bevacizumab Biosimilar Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Bevacizumab Biosimilar (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON BEVACIZUMAB BIOSIMILAR INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES BEVACIZUMAB BIOSIMILAR MARKET COMPETITION BY MANUFACTURERS

3.1 United States Bevacizumab Biosimilar Production and Share by Manufacturers (2015 and 2016)
3.2 United States Bevacizumab Biosimilar Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Bevacizumab Biosimilar Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Bevacizumab Biosimilar Manufacturing Base Distribution, Production Area and Product Type
3.5 Bevacizumab Biosimilar Market Competitive Situation and Trends
  3.5.1 Bevacizumab Biosimilar Market Concentration Rate
  3.5.2 Bevacizumab Biosimilar Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES BEVACIZUMAB BIOSIMILAR PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Bevacizumab Biosimilar Production and Market Share by Type (2012-2017)
4.2 United States Bevacizumab Biosimilar Revenue and Market Share by Type (2012-2017)
4.3 United States Bevacizumab Biosimilar Price by Type (2012-2017)
4.4 United States Bevacizumab Biosimilar Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES BEVACIZUMAB BIOSIMILAR MARKET ANALYSIS BY APPLICATION

5.1 United States Bevacizumab Biosimilar Consumption and Market Share by Application (2012-2017)
5.2 United States Bevacizumab Biosimilar Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES BEVACIZUMAB BIOSIMILAR MANUFACTURERS ANALYSIS

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Allergan
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Alnylam Pharmaceuticals
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Amgen
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Angstrom Pharmaceuticals
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Acceleron Pharma
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Biocon
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Bionomics
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 CASI Pharmaceuticals
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 BEVACIZUMAB BIOSIMILAR MANUFACTURING COST ANALYSIS

7.1 Bevacizumab Biosimilar Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Bevacizumab Biosimilar

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Bevacizumab Biosimilar Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Bevacizumab Biosimilar Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES BEVACIZUMAB BIOSIMILAR MARKET FORECAST (2017-2021)

11.1 United States Bevacizumab Biosimilar Production, Revenue Forecast (2017-2021)
11.2 United States Bevacizumab Biosimilar Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Bevacizumab Biosimilar Production Forecast by Type (2017-2021)
11.4 United States Bevacizumab Biosimilar Consumption Forecast by Application (2017-2021)
11.5 Bevacizumab Biosimilar Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Bevacizumab Biosimilar
Table Classification of Bevacizumab Biosimilar
Figure United States Sales Market Share of Bevacizumab Biosimilar by Type in 2015
Table Application of Bevacizumab Biosimilar
Figure United States Sales Market Share of Bevacizumab Biosimilar by Application in 2015
Figure United States Bevacizumab Biosimilar Sales and Growth Rate (2011-2021)
Figure United States Bevacizumab Biosimilar Revenue and Growth Rate (2011-2021)
Table United States Bevacizumab Biosimilar Sales of Key Manufacturers (2015 and 2016)
Table United States Bevacizumab Biosimilar Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Bevacizumab Biosimilar Sales Share by Manufacturers
Figure 2016 Bevacizumab Biosimilar Sales Share by Manufacturers
Table United States Bevacizumab Biosimilar Revenue by Manufacturers (2015 and 2016)
Table United States Bevacizumab Biosimilar Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Bevacizumab Biosimilar Revenue Share by Manufacturers
Table 2016 United States Bevacizumab Biosimilar Revenue Share by Manufacturers
Table United States Market Bevacizumab Biosimilar Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Bevacizumab Biosimilar Average Price of Key Manufacturers in 2015
Figure Bevacizumab Biosimilar Market Share of Top 3 Manufacturers
Figure Bevacizumab Biosimilar Market Share of Top 5 Manufacturers
Table United States Bevacizumab Biosimilar Sales by Type (2012-2017)
Table United States Bevacizumab Biosimilar Sales Share by Type (2012-2017)
Figure United States Bevacizumab Biosimilar Sales Market Share by Type in 2015
Table United States Bevacizumab Biosimilar Revenue and Market Share by Type (2012-2017)
Table United States Bevacizumab Biosimilar Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Bevacizumab Biosimilar by Type (2012-2017)
Table United States Bevacizumab Biosimilar Price by Type (2012-2017)
Figure United States Bevacizumab Biosimilar Sales Growth Rate by Type (2012-2017)
Table United States Bevacizumab Biosimilar Sales by Application (2012-2017)
Table United States Bevacizumab Biosimilar Sales Market Share by Application (2012-2017)
Figure United States Bevacizumab Biosimilar Sales Market Share by Application in 2015
Table United States Bevacizumab Biosimilar Sales Growth Rate by Application (2012-2017)
Figure United States Bevacizumab Biosimilar Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Bevacizumab Biosimilar Market Share (2012-2017)
Table Allergan Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Allergan Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Bevacizumab Biosimilar Market Share (2012-2017)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Alnylam Pharmaceuticals Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Alnylam Pharmaceuticals Bevacizumab Biosimilar Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amgen Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Bevacizumab Biosimilar Market Share (2012-2017)
Table Angstrom Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Angstrom Pharmaceuticals Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Angstrom Pharmaceuticals Bevacizumab Biosimilar Market Share (2012-2017)
Table Acceleron Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Acceleron Pharma Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Acceleron Pharma Bevacizumab Biosimilar Market Share (2012-2017)
Table Biocon Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Biocon Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Biocon Bevacizumab Biosimilar Market Share (2012-2017)
Table Bionomics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bionomics Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table Bionomics Bevacizumab Biosimilar Market Share (2012-2017)
Table CASI Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table CASI Pharmaceuticals Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2012-2017)
Table CASI Pharmaceuticals Bevacizumab Biosimilar Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bevacizumab Biosimilar
Figure Manufacturing Process Analysis of Bevacizumab Biosimilar
Figure Bevacizumab Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Bevacizumab Biosimilar Major Manufacturers in 2015
Table Major Buyers of Bevacizumab Biosimilar
Table Distributors/Traders List
Figure United States Bevacizumab Biosimilar Production and Growth Rate Forecast (2017-2021)
Figure United States Bevacizumab Biosimilar Revenue and Growth Rate Forecast (2017-2021)
Table United States Bevacizumab Biosimilar Production Forecast by Type (2017-2021)
Table United States Bevacizumab Biosimilar Consumption Forecast by Application (2017-2021)